4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Novavax, Inc. (NVAX) operates in the Biotechnology industry and is headquartered in Gaithersburg, United States with about 749 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, NVAX reported $1.1B in revenue and $440M in net income.
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine.
Interactive charts & full statements → Open the NVAX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $1.1B | $682M | $556M | $1.6B | — |
| Gross Profit | $1.1B | $479M | $213M | $696M | — |
| Operating Income (EBIT) | $551M | ($249M) | ($566M) | ($645M) | — |
| Net Income | $440M | ($188M) | ($545M) | ($658M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $140M | $147M | $70M | $239M | $667M |
| Gross Profit | $109M | $125M | $49M | $224M | $652M |
| Operating Income (EBIT) | ($15M) | $15M | ($81M) | $101M | $516M |
| Net Income | ($10M) | $18M | ($202M) | $106M | $519M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.2B | $1.6B | $1.8B | $2.3B | — |
| Total Liabilities | $1.3B | $2.2B | $2.5B | $2.9B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NVAX viewer.
About TickerBase · Data methodology & sources